Has anyone heard of this new vaccine, developed by Cleveland Clinic, for triple-negative breast cancer?
- The FDA has approved a triple-negative breast cancer vaccine for use in human clinical trials.
- The vaccine was developed by researchers at the Cleveland Clinic in Ohio and works by training the immune system to kill cells that express the protein alpha-lactalbumin.
- The technology used to develop the vaccine could be applicable to cancers beyond breast cancer as well.
2/18/2021, DCIS/IDC, Left, 1cm, Stage IIB, Grade 3, 4/22 nodes, ER+/PR+, HER2- (FISH)
Log in to post a reply